Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer

Neoadjuvant therapy has been widely employed in the treatment of rectal cancer, demonstrating its utility in reducing tumor volume, downstaging tumors, and improving patient prognosis. It has become the standard preoperative treatment modality for locally advanced rectal cancer. However, the efficac...

Full description

Bibliographic Details
Main Authors: Guilin Yu, Huanyu Chi, Guohua Zhao, Yue Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1375334/full
_version_ 1797224255711084544
author Guilin Yu
Huanyu Chi
Huanyu Chi
Guohua Zhao
Yue Wang
author_facet Guilin Yu
Huanyu Chi
Huanyu Chi
Guohua Zhao
Yue Wang
author_sort Guilin Yu
collection DOAJ
description Neoadjuvant therapy has been widely employed in the treatment of rectal cancer, demonstrating its utility in reducing tumor volume, downstaging tumors, and improving patient prognosis. It has become the standard preoperative treatment modality for locally advanced rectal cancer. However, the efficacy of neoadjuvant therapy varies significantly among patients, with notable differences in tumor regression outcomes. In some cases, patients exhibit substantial tumor regression, even achieving pathological complete response. The assessment of tumor regression outcomes holds crucial significance for determining surgical approaches and establishing safe margins. Nonetheless, current research on tumor regression patterns remains limited, and there is considerable controversy surrounding the determination of a safe margin after neoadjuvant therapy. In light of these factors, this study aims to summarize the primary patterns of tumor regression observed following neoadjuvant therapy for rectal cancer, categorizing them into three types: tumor shrinkage, tumor fragmentation, and mucinous lake formation. Furthermore, a comparison will be made between gross and microscopic tumor regression, highlighting the asynchronous nature of regression in the two contexts. Additionally, this study will analyze the safety of non-surgical treatment in patients who achieve complete clinical response, elucidating the necessity of surgical intervention. Lastly, the study will investigate the optimal range for safe surgical resection margins and explore the concept of a safe margin distance post-neoadjuvant therapy.
first_indexed 2024-04-24T13:50:13Z
format Article
id doaj.art-3a6e581120414c76b441f479dbbaa5bd
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-24T13:50:13Z
publishDate 2024-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-3a6e581120414c76b441f479dbbaa5bd2024-04-04T05:04:03ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-04-011410.3389/fonc.2024.13753341375334Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancerGuilin Yu0Huanyu Chi1Huanyu Chi2Guohua Zhao3Yue Wang4Department of General Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, ChinaDepartment of General Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, ChinaThe Second Clinical College, Dalian Medical University, Dalian, ChinaDepartment of General Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, ChinaDepartment of General Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, ChinaNeoadjuvant therapy has been widely employed in the treatment of rectal cancer, demonstrating its utility in reducing tumor volume, downstaging tumors, and improving patient prognosis. It has become the standard preoperative treatment modality for locally advanced rectal cancer. However, the efficacy of neoadjuvant therapy varies significantly among patients, with notable differences in tumor regression outcomes. In some cases, patients exhibit substantial tumor regression, even achieving pathological complete response. The assessment of tumor regression outcomes holds crucial significance for determining surgical approaches and establishing safe margins. Nonetheless, current research on tumor regression patterns remains limited, and there is considerable controversy surrounding the determination of a safe margin after neoadjuvant therapy. In light of these factors, this study aims to summarize the primary patterns of tumor regression observed following neoadjuvant therapy for rectal cancer, categorizing them into three types: tumor shrinkage, tumor fragmentation, and mucinous lake formation. Furthermore, a comparison will be made between gross and microscopic tumor regression, highlighting the asynchronous nature of regression in the two contexts. Additionally, this study will analyze the safety of non-surgical treatment in patients who achieve complete clinical response, elucidating the necessity of surgical intervention. Lastly, the study will investigate the optimal range for safe surgical resection margins and explore the concept of a safe margin distance post-neoadjuvant therapy.https://www.frontiersin.org/articles/10.3389/fonc.2024.1375334/fullrectal tumorneoadjuvant therapydistal resection margintumor regressionsafe distance
spellingShingle Guilin Yu
Huanyu Chi
Huanyu Chi
Guohua Zhao
Yue Wang
Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer
Frontiers in Oncology
rectal tumor
neoadjuvant therapy
distal resection margin
tumor regression
safe distance
title Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer
title_full Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer
title_fullStr Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer
title_full_unstemmed Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer
title_short Tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer
title_sort tumor regression and safe distance of distal margin after neoadjuvant therapy for rectal cancer
topic rectal tumor
neoadjuvant therapy
distal resection margin
tumor regression
safe distance
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1375334/full
work_keys_str_mv AT guilinyu tumorregressionandsafedistanceofdistalmarginafterneoadjuvanttherapyforrectalcancer
AT huanyuchi tumorregressionandsafedistanceofdistalmarginafterneoadjuvanttherapyforrectalcancer
AT huanyuchi tumorregressionandsafedistanceofdistalmarginafterneoadjuvanttherapyforrectalcancer
AT guohuazhao tumorregressionandsafedistanceofdistalmarginafterneoadjuvanttherapyforrectalcancer
AT yuewang tumorregressionandsafedistanceofdistalmarginafterneoadjuvanttherapyforrectalcancer